Skip to content

Earnings yield at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
6.8%+6.3pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
7.3%+0.6pp
Avanos Medical logo
Avanos MedicalAVNS
-11.4%-5.1pp
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
0.6%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
-1%-4.4pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
13.7%+9.2pp

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s earnings yield?
Collegium Pharmaceutical, Inc. (COLL) reported earnings yield of 7.1% in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s earnings yield changed year-over-year?
Collegium Pharmaceutical, Inc.'s earnings yield increased by 56.0% year-over-year, from 4.6% to 7.1%.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s earnings yield?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s earnings yield has grown at a 2.1% compound annual growth rate (CAGR), from 3.9% to 4.3%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.